Premium
Conceptual and technical insights into the basis of neuromuscular monitoring
Author(s) -
Naguib M.,
Brull S. J.,
Johnson K. B.
Publication year - 2017
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/anae.13738
Subject(s) - medicine , neuromuscular blocking agents , status quo , neuromuscular monitoring , neuromuscular blockade , weakness , intensive care medicine , block (permutation group theory) , anesthesia , surgery , geometry , mathematics , economics , market economy
Summary Unrecognised postoperative residual neuromuscular block remains a frequent occurrence in recovery rooms. Evidence indicates that current practice continues to perpetuate the status quo, in which 10–40% of patients experience postoperative residual weakness. A departure from the current practice requires small efforts on the clinicians’ part. This review addresses several selected core questions regarding neuromuscular blockade monitoring and provides a framework to rationally discuss and develop basic guidelines for the use of neuromuscular blocking agents in patient care.